The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial
Open accessAbstract
Accumulating evidence implicates gut microbiota as promising targets for the treatment of type 2 diabetes mellitus (T2DM). With a randomized clinical trial, we tested the hypothesis that alteration of gut microbiota may be involved in the alleviation of T2DM with hyperlipidemia by metformin and a specifically designed herbal formula (AMC). Four hundred fifty patients with T2DM and hyperlipidemia were randomly assigned to either the metformin- or AMC-treated group. After 12 weeks of treatment, 100 patients were randomly selected from each group and assessed for clinical improvement. The effects of the two drugs on the intestinal microbiota were evaluated by analyzing the V3 and V4 regions of the 16S rRNA gene by Illumina sequencing and multivariate statistical methods. Both metformin and AMC significantly alleviated hyperglycemia and hyperlipidemia and shifted gut microbiota structure in diabetic patients. They significantly increased a coabundant group represented by Blautia spp., which significantly correlated with the improvements in glucose and lipid homeostasis. However, AMC showed better efficacies in improving homeostasis model assessment of insulin resistance (HOMA-IR) and plasma triglyceride and also exerted a larger effect on gut microbiota. Furthermore, only AMC increased the coabundant group represented by Faecalibacterium spp., which was previously reported to be associated with the alleviation of T2DM in a randomized clinical trial. Metformin and the Chinese herbal formula may ameliorate type 2 diabetes with hyperlipidemia via enriching beneficial bacteria, such as Blautia and Faecalibacterium spp. IMPORTANCE Metabolic diseases such as T2DM and obesity have become a worldwide public health threat. Accumulating evidence indicates that gut microbiota can causatively arouse metabolic diseases, and thus the gut microbiota serves as a promising target for disease control. In this study, we evaluated the role of gut microbiota during improvements in hyperglycemia and hyperlipidemia by two drugs: metformin and a specifically designed Chinese herbal formula (AMC) for diabetic patients with hyperlipidemia. Both drugs significantly ameliorated blood glucose and lipid levels and shifted the gut microbiota. Blautia spp. were identified as being associated with improvements in glucose and lipid homeostasis for both drugs. AMC exerted larger effects on the gut microbiota together with better efficacies in improving HOMA-IR and plasma triglyceride levels, which were associated with the enrichment of Faecalibacterium spp. In brief, these data suggest that gut microbiota might be involved in the alleviation of diabetes with hyperlipidemia by metformin and the AMC herbal formula.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Duca, F. A., Sakar, Y., Lepage, P., Devime, F., Langelier, B., Doré, J., & Covasa, M. (2014) · Diabetes · doi:10.2337/db13-1526 · Cited by 161
RetractedQIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“Transplantation of the gut microbiota from the obese human gut can transfer the obese phenotypes to germfree mice, indicating the causative role of gut microbiota in the development of obesity and metabolic diseases (7).”
BackgroundA metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Self-citationRole of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“Numerous studies showed that metformin might function by inhibition of hepatic gluconeogenesis via activation of the AMP-activated protein kinase (AMPK) signaling pathway (14, 15).”
BackgroundSokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Gut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115
Inferring Correlation Networks from Genomic Survey Data
Friedman, J., & Alm, E. J. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002687 · Cited by 2,706
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., et al. (2015) · Nature · doi:10.1038/nature15766 · Cited by 2,116
Self-citationMetabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
Vijay-Kumar, M., Aitken, J. D., Carvalho, F. A., Cullender, T. C., Mwangi, S., Srinivasan, S., Sitaraman, S. V., Knight, R., Ley, R. E., & Gewirtz, A. T. (2010) · Science · doi:10.1126/science.1179721 · Cited by 2,068
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Shin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T. W., Lee, M.-S., & Bae, J.-W. (2014) · Gut · doi:10.1136/gutjnl-2012-303839 · Cited by 1,550
Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss
Furet, J.-P., Kong, L.-C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.-L., Mariat, D., Corthier, G., Doré, J., Henegar, C., et al. (2010) · Diabetes · doi:10.2337/db10-0253 · Cited by 1,173 · cited 1×
“prausnitzii was linked with the reduction of a low-grade inflammatory state during the alleviation of obesity and diabetes in patients receiving Roux-en-Y gastric bypass (RYGB) surgery (45).”
BackgroundSymbiotic gut microbes modulate human metabolic phenotypes
Li, M., Wang, B., Zhang, M., Rantalainen, M., Wang, S., Zhou, H., Zhang, Y., Shen, J., Pang, X., Zhang, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712038105 · Cited by 1,144
Self-citationHuman Gut Microbiota Changes Reveal the Progression of Glucose Intolerance
Zhang, X., Shen, D., Fang, Z., Jie, Z., Qiu, X., Zhang, C., Chen, Y., & Ji, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071108 · Cited by 946
Self-citationQuévrain, E., Maubert, M. A., Michon, C., Chain, F., Marquant, R., Tailhades, J., Miquel, S., Carlier, L., Bermúdez-Humarán, L. G., Pigneur, B., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-307649 · Cited by 841
The gut microbiota and obesity: from correlation to causality
Zhao, L. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3089 · Cited by 838
Self-citationMurri, M., Leiva, I., Gomez-Zumaquero, J. M., Tinahones, F. J., Cardona, F., Soriguer, F., & Queipo-Ortuño, M. I. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-46 · Cited by 765
An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice
Fei, N., & Zhao, L. (2013) · The ISME Journal · doi:10.1038/ismej.2012.153 · Cited by 750
Self-citationIntestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
Jenq, R. R., Taur, Y., Devlin, S. M., Ponce, D. M., Goldberg, J. D., Ahr, K. F., Littmann, E. R., Ling, L., Gobourne, A. C., Miller, L. C., et al. (2015) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2015.04.016 · Cited by 748
Duncan, S. H., Hold, G. L., Harmsen, H. J. M., Stewart, C. S., & Flint, H. J. (2002) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/00207713-52-6-2141 · Cited by 708
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome
Saulnier, D. M., Riehle, K., Mistretta, T., Diaz, M., Mandal, D., Raza, S., Weidler, E. M., Qin, X., Coarfa, C., Milosavljevic, A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.072 · Cited by 672
Zhang, X., Zhao, Y., Xu, J., Xue, Z., Zhang, M., Pang, X., Zhang, X., & Zhao, L. (2015) · Scientific Reports · doi:10.1038/srep14405 · Cited by 630 · cited 3×
“, a population of SCFA producers in the metformin-treated group, in agreement with our previous animal study (18).”
BackgroundResultInfluentialSelf-citationZhang, X., Zhao, Y., Zhang, M., Pang, X., Xu, J., Kang, C., Li, M., Zhang, C., Zhang, Z., Zhang, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042529 · Cited by 615 · cited 1×
“AMC contains the herb Coptis chinensis, whose major component, berberine, has been clinically demonstrated to be able to alleviate diabetes with hyperlipidemia, possibly via increasing SCFA-producing bacteria as shown in rats with HFD-induced obesity (29).”
BackgroundSelf-citationTreatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
Zhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., Huo, L., Wang, M., Hong, J., Wu, P., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2404 · Cited by 573 · cited 1×
“chinensis (24), Aloe vera (25, 26), and red yeast rice (27, 28), have profound effects in ameliorating blood glucose and lipid levels in various clinical trials and animal experiments.”
BackgroundHe, L., Sabet, A., Djedjos, S., Miller, R., Sun, X., Hussain, M. A., Radovick, S., & Wondisford, F. E. (2009) · Cell · doi:10.1016/j.cell.2009.03.016 · Cited by 481
Xu, J., Lian, F., Zhao, L., Zhao, Y., Chen, X., Zhang, X., Guo, Y., Zhang, C., Zhou, Q., Xue, Z., et al. (2015) · The ISME Journal · doi:10.1038/ismej.2014.177 · Cited by 422
Self-citationZhang, C., Yin, A., Li, H., Wang, R., Wu, G., Shen, J., Zhang, M., Wang, L., Hou, Y., Ouyang, H., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.07.007 · Cited by 416
Self-citationDuncan, S. H., Hold, G. L., Barcenilla, A., Stewart, C. S., & Flint, H. J. (2002) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/00207713-52-5-1615 · Cited by 367
Wulffelé, M. G., Kooy, A., de Zeeuw, D., Stehouwer, C. D. A., & Gansevoort, R. T. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01328.x · Cited by 359
Miquel, S., Leclerc, M., Martin, R., Chain, F., Lenoir, M., Raguideau, S., Hudault, S., Bridonneau, C., Northen, T., Bowen, B., et al. (2015) · mBio · doi:10.1128/mbio.00300-15 · Cited by 318
Martín, R., Miquel, S., Chain, F., Natividad, J. M., Jury, J., Lu, J., Sokol, H., Theodorou, V., Bercik, P., Verdu, E. F., et al. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0400-1 · Cited by 309
Baxter, N. T., Zackular, J. P., Chen, G. Y., & Schloss, P. D. (2014) · Microbiome · doi:10.1186/2049-2618-2-20 · Cited by 299
Antihyperglycemic effects of three extracts from Momordica charantia
Virdi, J., Sivakami, S., Shahani, S., Suthar, A. C., Banavalikar, M. M., & Biyani, M. K. (2003) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(03)00184-3 · Cited by 291
Inflammation and endoplasmic reticulum stress in obesity and diabetes
Hotamisligil, G. S. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.238 · Cited by 285
Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients: A Randomized Trial
Becker, D. J., Gordon, R. Y., Halbert, S. C., French, B., Morris, P. B., & Rader, D. J. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-12-200906160-00006 · Cited by 275
Neyrinck, A. M., Possemiers, S., Verstraete, W., De Backer, F., Cani, P. D., & Delzenne, N. M. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.10.008 · Cited by 244
Zhang, Q., Wu, Y., Wang, J., Wu, G., Long, W., Xue, Z., Wang, L., Zhang, X., Pang, X., Zhao, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep27572 · Cited by 233
Self-citationKim, K., Kim, H., Kwon, J., Lee, S., Kong, H., Im, S.-A., Lee, Y.-H., Lee, Y.-R., Oh, S.-T., Jo, T. H., et al. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.02.014 · Cited by 194
Fuangchan, A., Sonthisombat, P., Seubnukarn, T., Chanouan, R., Chotchaisuwat, P., Sirigulsatien, V., Ingkaninan, K., Plianbangchang, P., & Haines, S. T. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.12.045 · Cited by 184
Rossi, O., Khan, M. T., Schwarzer, M., Hudcovic, T., Šrůtková, D., Duncan, S. H., Stolte, E. H., Kozáková, H., Flint, H. J., Samsom, J. N., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123013 · Cited by 155
Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model
Cittadini, A., Napoli, R., Monti, M. G., Rea, D., Longobardi, S., Netti, P. A., Walser, M., Samà, M., Aimaretti, G., Isgaard, J., et al. (2012) · Diabetes · doi:10.2337/db11-1132 · Cited by 130
Blautia faecis sp. nov., isolated from human faeces
Park, S.-K., Kim, M., & Bae, J. (2012) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijs.0.036541-0 · Cited by 107
Sanugul, K., Akao, T., Li, Y., Kakiuchi, N., Nakamura, N., & Hattori, M. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1672 · Cited by 98
Getting away from glucose: fanning the flames of obesity-induced inflammation
Shoelson, S. E., & Goldfine, A. B. (2009) · Nature Medicine · doi:10.1038/nm0409-373 · Cited by 98
Choi, H.-C., Kim, S.-J., Son, K. Y., Oh, B., & Cho, B.-L. (2013) · Nutrition · doi:10.1016/j.nut.2013.02.015 · Cited by 91
Bonora, E., CIGOLINI, M., Bosello, O., Zancanaro, C., Capretti, L., Zavaroni, I., Coscelli, C., & BUTTURINI, U. (1984) · Current Medical Research and Opinion · doi:10.1185/03007998409109558 · Cited by 85
Na, L., Zhang, Q., Jiang, S., Du, S., Zhang, W., Li, Y., Sun, C., & Niu, Y. (2015) · Scientific Reports · doi:10.1038/srep10344 · Cited by 82 · cited 1×
“acids, and HOMA-IR in overweight patients with hyperlipidemia (51), but the pharma-”
BackgroundBlautia stercoris sp. nov., isolated from human faeces
Park, S.-K., Kim, M., Roh, S. W., & Bae, J. (2011) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijs.0.031625-0 · Cited by 65
Verhoeven, V., der Auwera, A. V., Gaal, L. V., Remmen, R., Apers, S., Stalpaert, M., Wens, J., & Hermans, N. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0576-9 · Cited by 64
Pruski, M., Krysiak, R. G., & Okopień, B. (2009) · Diabetes Care · doi:10.2337/dc08-2335 · Cited by 48
Han, J., Yang, N., Zhang, F., Zhang, C., Liang, F., Xie, W., & Chen, W. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.05.016 · Cited by 39
Self-citationMetformin treatment improves weight and dyslipidemia in children with metabolic syndrome
Luong, D. Q., Oster, R. A., & Ashraf, A. P. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0201 · Cited by 29
Cited by
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
Self-citationRole of gut microbiota in type 2 diabetes pathophysiology
Gurung, M., Li, Z., You, H., Rodrigues, R., Jump, D. B., Morgun, A., & Shulzhenko, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.051 · Cited by 1,708
Blautia —a new functional genus with potential probiotic properties?
Liu, X., Mao, B., Gu, J., Wu, J., Cui, S., Wang, G., Zhao, J., Zhang, H., & Chen, W. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1875796 · Cited by 1,381
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Foretz, M., Guigas, B., & Viollet, B. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0242-2 · Cited by 686
Wan, Y., Wang, F., Yuan, J., Li, J., Jiang, D., Zhang, J., Li, H., Wang, R., Tang, J., Huang, T., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317609 · Cited by 598
Metadata
- Authors
- Tong, X., Xu, J., Lian, F., Yu, X., Zhao, Y., Xu, L., Zhang, M., Zhao, X., Shen, J., Wu, S., Pang, X., Tian, J., Zhang, C., Zhou, Q., Wang, L., Pang, B., Chen, F., Peng, Z., Wang, J., Zhen, Z., Fang, C., Li, M., Chen, L., & Zhao, L.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2018-07-05
- Volume
- 9
- Issue
- 3
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- OpenAlex
- W2803132482
- Cited by
- 378
- References
- 55
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.